In human melanoma metastases, increased CD138+ plasma cell counts showed a trend to better patient survival (Erdag et al., 2012) and patients with primary melanomas of > 2 mm in thickness and enriched for sheets/clusters of CD138+ IgA-expressing plasma cells had a worse overall survival. This evidence concerns the gene CD79A and melanoma.